ROTEC - Chairman of the board
Mr. David Waxman brings ROTEC over twenty years of experience as an executive manager in global corporations. Before joining Rotec, Mr. Waxman served as CEO of IDE Technologies Ltd., a large water desalination company with global operations and as North American Representative, Atlantium Ltd. a large provider of UV base disinfection devices, Dead Sea Works Ltd. (ICL group). Mr. Waxman currently serves as Chairman and Director of several companies in the environmental sector, as well as Chairman of the Water Industries in the Manufacturers Association of Israel. Mr. Waxman holds an MBA in Finance and Marketing, and a Post Graduate degree in Marketing from Tel Aviv University, Israel.
ROTEC – Board member and lead Investor
Mr. Shitzer brings to ROTEC over 18 years of experiance in executive managing positions in the private enviromental sector, with specific experiance in development of technologies for the Clean-tech sector. Being with ROTEC since 2012, Mr. Shitzer is also the chairman of a leading israeli chemical distributor AST- Clean Water Technologies, operating in the fields of filtration, desalination and chemical oxidation. Mr. Shitzer holds an MBA in Finance and Marketing from City Of London University, and a post graduate degree in Economics and Marketing from Tel Aviv University, Israel.
BDB - Chief Executive Officer
Avi Broder is a "Big 4" CPA who has over 12 years of experience in the Israeli hi-tech industry, both in finance and strategy management with dozens of startups. Avi Broder served as CFO for BRM Technologies, founded a CFO outsourcing consulting practice, he was founder and co manager of ERB finance, founder and board member of ESOP Excellence , largest option management service provider in Israel and since 2007 to date, he is founder and CEO of BDB, a technology accelerator and investment company focusing on Cleantech water technologies and medical devices .
BGN - Chief Executive Officer
Mr. Cohen serves as BGN CEO since 2004, bringing to the position 20 years of managerial experience. Prior to joining BGN, Mr. Cohen was the Deputy General Manager of Pharma-Israel, The Multinational Pharmaceutical Companies Association. Previously, he was the Director of Finance & Business Development for Novartis Consumer Health and Gerber Baby Food at its regional offices. He began his managerial career at Kibbutz Harish, where he served as its General Manager. Mr. Cohen currently sits on the boards of BotanoCap, OmniLogos, Amorphical, MultiPhy, PixelScan, CartiHeal and other privately-held companies. He also sits on the board of Deutsche Telekom Labs at BGU.
Mr. Cohen holds an Executive MBA from the University of Bradford, UK, and a BA in Economics from Ruppin Academic Center.
BGN - VP Business Development
Dr. Horovitz joined BGN in 1997 following 20 years of Research and Development positions in academy and industry and 5 years of International Marketing and Business Development. Dr. Horovitz serves as VP for Business Development and is responsible for Licensing and Intellectual Property at BGN.
Dr. Horovitz is a graduate of Bar Ilan University and the Hebrew University and holds a Ph.D in Molecular Biology from the Weizmann Institute of Science.